Publicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (38)

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. Clinical features and prognosis of prosthetic valve endocarditis due to Staphylococcus aureus

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 10, pp. 1989-2000

  3. Cutibacterium Species Valvular and Cardiac Device-Related Infective Endocarditis: Contemporary Data from the GAMES Prospective Cohort (2008-2023)

    Clinical Infectious Diseases, Vol. 79, Núm. 3, pp. 663-671

  4. DOLAMA 200: Effectiveness and Safety of a Dual Therapy with Dolutegravir Plus Lamivudine in Treatment-Experienced HIV-1 Infected Real World Participants in Spain

    Viruses, Vol. 16, Núm. 2

  5. Prevalence and prognostic impact of stroke in a national cohort of infective endocarditis

    International Journal of Stroke, Vol. 19, Núm. 9, pp. 989-998

  6. The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers

    Journal of Clinical Investigation, Vol. 134, Núm. 8

2023

  1. EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 3

2022

  1. Ampicillin plus ceftriaxone combined therapy for enterococcus faecalis infective endocarditis in opat

    Journal of Clinical Medicine, Vol. 11, Núm. 1

2021

  1. Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study

    Infectious Diseases, Vol. 53, Núm. 10, pp. 755-763

  2. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

  3. Mural Endocarditis: The GAMES Registry Series and Review of the Literature

    Infectious Diseases and Therapy, Vol. 10, Núm. 4, pp. 2749-2764

  4. Prevalence of Colorectal Neoplasms Among Patients With Enterococcus faecalis Endocarditis in the GAMES Cohort (2008–2017)

    Mayo Clinic Proceedings, Vol. 96, Núm. 1, pp. 132-146

  5. Redefining therapeutic success in HIV patients: An expert view

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2501-2518

2020

  1. A Contemporary Picture of Enterococcal Endocarditis

    Journal of the American College of Cardiology, Vol. 75, Núm. 5, pp. 482-494

  2. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis

    BMC Infectious Diseases, Vol. 20, Núm. 1

  3. Genetic diversity of HIV in seminal plasma remains higher than in blood after short-term antiretroviral therapy

    Sexually Transmitted Infections, Vol. 96, Núm. 5, pp. 337-341

2019

  1. DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients

    Medicine (United States), Vol. 98, Núm. 32

  2. Left endocarditis, changes in the new millennium

    Medicina Clinica, Vol. 153, Núm. 2, pp. 63-66

  3. Left-sided infective endocarditis caused by Streptococcus agalactiae: rare and serious

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 2, pp. 265-275

  4. Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES Cohort

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 69, Núm. 10, pp. 1690-1700